Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren in addition to standard therapy after hospitalization for acute decompensated heart failure
2009-010236-18Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Acute Heart Failure (AHF) and heart failure (HF) comparing Aliskiren plus standard therapy with Placebo plus standard therapy (2 arms). Primary endpoint: Primary efficacy endpoint. Started Apr 2009; status: completed.
02
Drugs
aliskiren
03
Conditions
Acute Heart Failure (AHF)heart failure (HF)
Beyond the preview
Go deeper on 2009-010236-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010236-18.